Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/154363
Full metadata record
DC FieldValueLanguage
dc.creatorRuano, L
dc.creatorSevero, M
dc.creatorSousa, A
dc.creatorRuano, C
dc.creatorBranco, M
dc.creatorBarreto, R
dc.creatorMoreira, S
dc.creatorAraújo, N
dc.creatorPinto, P
dc.creatorPais, J
dc.creatorLunet, N
dc.creatorCruz, VT
dc.date.accessioned2023-11-14T12:03:53Z-
dc.date.available2023-11-14T12:03:53Z-
dc.date.issued2019
dc.identifier.issn1387-2877
dc.identifier.issn1875-8908
dc.identifier.urihttps://hdl.handle.net/10216/154363-
dc.description.abstractRepeated measurements could be helpful to identify patients with early cognitive decline. We compare the variation of cognitive performance over one year in patients with mild cognitive impairment (MCI) and healthy individuals using the Brain on Track self-applied computerized test (BoT). The study was initiated 30 patients with probable MCI and 377 controls from a population-based cohort, who performed the BoT test from home every three months for one year. The scores were compared using a linear mixed-effects model. All participants increased their scores in the first tests, after 120 days MCI patients started to decline, with a statistically significant higher rate. The area under the curve to detect MCI was 0.94. We identified a significant decline in cognitive performance over one year in patients with MCI using BoT and the test presented a high discriminative ability.
dc.description.sponsorshipThe authors gratefully acknowledge the participants enrolled in EpiPorto for their kindness, all members of the research team for their enthusiasm and perseverance, and the participating hospitals and their staff for their help and support. The authors would also like to thank Rute Costa for her important role in collecting patient data. This research project was partly financed by the Programa Operacional Competitividade e Internacionalizac¸ ˜ao (POCI) (POCI-01-0145-509 FEDER-016867), the Programa Operacional Regional do Norte 2014/2020 (NORTE 2020) (NORTE-01-0145-FEDER-000003) and by the Fundac¸ ˜ao para a Ciˆencia e a Tecnologia, in the context of the Epidemiology Research Unit - Instituto de Sa´ude P´ublica da Universidade do Porto (EPIUnit) (POCI-01-0145-FEDER-006862; FCT UID/DTP/04750/2013), and the PhD Grant SFRH/BD/119390/2016 (Nat´alia Ara´ujo), co-funded by the FCT and the POCH/FSE Program. VTC and JP have a shareholder position at Neuroinova, Lda a start-up company that conceived Brain on Track, holds registered trademark and commercialization rights. Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/19-0631).
dc.language.isoeng
dc.publisherIOS Press
dc.relation.ispartofJ Alzheimers Dis. 2019;71(2):541-548. doi: 10.3233/JAD-190631.
dc.rightsrestrictedAccess
dc.titleTracking Cognitive Performance in the General Population and in Patients with Mild Cognitive Impairment with a Self-Applied Computerized Test (Brain on Track)
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto
dc.identifier.doi10.3233/JAD-190631
dc.relation.publisherversionhttps://content.iospress.com/articles/journal-of-alzheimers-disease/jad190631
Appears in Collections:ISPUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
ruano-jad-2019.pdf
  Restricted Access
130.44 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.